Bio-Rad Laboratories, Inc. Stock Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
03:55:01 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 331.00 EUR | -0.96% |
|
-0.72% | +29.40% |
| Market Cap | 10.22B 8.79B 8.27B 7.56B 14.14B 965B 14.17B 97.75B 37.93B 495B 38.37B 37.53B 1,595B | P/E 2026 * |
46.4x | P/E 2027 * | 45.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47B 8.15B 7.67B 7B 13.1B 894B 13.14B 90.58B 35.15B 459B 35.55B 34.78B 1,478B | EV / Sales 2026 * |
3.68x | EV / Sales 2027 * | 3.51x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Boerse Muenchen
| BUWA | Real-time | |
|
Tradegate
| BUWA | Real-time | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Deutsche Boerse AG
| BUWA | Delayed |
Last Transcript : Bio-Rad Laboratories, Inc.
| 1 day | -0.96% | ||
| 1 week | -0.72% | ||
| Current month | -0.54% | ||
| 1 month | +14.93% | ||
| 3 months | +25.95% | ||
| 6 months | +35.66% | ||
| Current year | +29.40% |
| 1 week | 322.4 |  | 334.8 |
| 1 month | 289.2 | | 338.4 |
| Current year | 204.6 | | 338.4 |
| 1 year | 204.6 | | 338.4 |
| 3 years | 187.35 | | 355.2 |
| 5 years | 187.35 | | 700 |
| 10 years | 133.36 | | 700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -0.72% | - | - | 10.22B | |
| -0.42% | -3.68% | -18.43% | +5.33% | 187B | |
| +1.15% | +3.22% | +1.42% | +14.66% | 120B | |
| -1.86% | +2.77% | +13.07% | +89.16% | 63.15B | |
| -1.31% | -1.09% | +22.44% | +46.84% | 51.75B | |
| -1.54% | -2.52% | -3.41% | -33.66% | 50.32B | |
| -2.02% | -3.22% | +8.84% | -13.73% | 33.17B | |
| 0.00% | +3.71% | - | - | 32.1B | |
| -0.81% | +0.74% | +37.34% | -16.61% | 23.93B | |
| -1.44% | -4.21% | -7.37% | +11.97% | 22.99B | |
| Average | -0.92% | -0.07% | +6.74% | +12.99% | 65.03B | |
| Weighted average by Cap. | -0.56% | +0.02% | -0.82% | +15.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.21B 2.08B 1.9B 3.56B 243B 3.57B 24.62B 9.55B 125B 9.66B 9.45B 402B | 2.63B 2.27B 2.13B 1.95B 3.64B 249B 3.65B 25.19B 9.78B 128B 9.89B 9.67B 411B |
| Net income | 225M 194M 182M 166M 311M 21.24B 312M 2.15B 835M 10.9B 845M 826M 35.11B | 230M 198M 186M 170M 318M 21.72B 319M 2.2B 854M 11.14B 864M 845M 35.89B |
| Net Debt | -749M -645M -606M -554M -1.04B -70.72B -1.04B -7.17B -2.78B -36.28B -2.81B -2.75B -117B | -965M -831M -782M -714M -1.34B -91.15B -1.34B -9.24B -3.58B -46.77B -3.63B -3.55B -151B |
| Date | Price | Change |
|---|---|---|
| 26-09-04 | €331.00 | -0.96% |
| 26-09-03 | €334.20 | -0.18% |
| 26-09-02 | €334.80 | +2.14% |
| 26-09-01 | €327.80 | -1.50% |
| 26-08-31 | €332.80 | -0.18% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
Select your edition
All financial news and data tailored to specific country editions
